Myelin Degeneration: Clinical Trials

2 trials for Myelin Degeneration, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1
Phase 41Completed 1

Follow Myelin Degeneration: new trials by email Literature Review of Myelin Degeneration trials Research Report on Myelin Degeneration

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound - Central Auditory Processing Disorder, Hearing Impaired (Partially)
Phase 1 / Phase 2RecruitingUniversity of Colorado, Denver3442025-03-312026-04-30
The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia
Aripiprazole - Schizophrenia, Myelin Degeneration
Phase 4CompletedFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico152022-08-012024-12-27

Narrower conditions

Auditory Diseases, Central (1)  ·  Cognition Disorders (1)  ·  Hearing Disorders (1)  ·  Hearing Loss (1)  ·  Hearing Loss, Hidden (1)  ·  Hearing Loss, Noise-Induced (1)  ·  Hearing Loss, Sensorineural (1)  ·  Language Development Disorders (1)  ·  Presbycusis (1)  ·  Schizophrenia (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Communication Disorders (1)  ·  Ear Diseases (1)  ·  Language Disorders (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurocognitive Disorders (1)  ·  Neurologic Manifestations (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Retrocochlear Diseases (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Sensation Disorders (1)

Interventions

Aripiprazole (1)  ·  Clemastine (1)  ·  Placebo Effect (1)

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  University of Colorado, Denver (1)

Countries

Italy (1)  ·  United States (1)

Top investigators

Achim Klug, PhD (1)  ·  Massimo C Mauri, Professor (1)  ·  Paolo Brambilla, Professor (1)  ·  Samuel A Budoff, PhD, MS (1)